Clinical significance of sperm DNA damage in assisted reproduction outcome by Simon, L. et al.
Clinical significance of sperm DNA damage in assisted
reproduction outcome
Simon, L., Stevenson, M., Lutton, D., McManus, J., Lewis, S., & Brunborg, G. (2010). Clinical significance of
sperm DNA damage in assisted reproduction outcome. Human Reproduction, 25(7), 1594-1608. DOI:
10.1093/humrep/deq103
Published in:
Human Reproduction
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:15. Feb. 2017
ORIGINAL ARTICLE Andrology
Clinical signiﬁcance of sperm DNA
damage in assisted reproduction
outcome
Luke Simon1, Gunnar Brunborg2, Michael Stevenson3,
Deborah Lutton4, Joanne McManus4, and Sheena E.M. Lewis1,*
1Centre for Public Health, Reproductive Medicine, Institute of Clinical Science, Queens University of Belfast, Grosvenor Road, Belfast BT12
6BJ, UK 2Norwegian Institute of Public Health, PO Box 4404, Nydalen, Oslo N-0403, Norway 3Centre for Public Health, Mulhouse Building,
Queens University of Belfast, Grosvenor Road, Belfast BT12 6BJ, UK 4Regional Fertility Centre, Royal Jubilee Maternity Service, Grosvenor
Road, Belfast BT12 6BA, UK
*Correspondence address. Tel: +44-28-9063-3987; Fax: +44-28-9032-8247; E-mail: s.e.lewis@qub.ac.uk
Submitted on January 27, 2010; resubmitted on March 3, 2010; accepted on March 29, 2010
background: Sperm DNA damage shows great promise as a biomarker of infertility. The study aim is to determine the usefulness of
DNA fragmentation (DF), including modiﬁed bases (MB), to predict assisted reproduction treatment (ART) outcomes.
methods: DF in 360 couples (230 IVF and 130 ICSI) was measured by the alkaline Comet assay in semen and in sperm following density
gradient centrifugation (DGC) and compared with fertilization rate (FR), embryo cumulative scores (ECS1) for the total number of embryos/
treatment, embryos transferred (ECS2), clinical pregnancy (CP) and spontaneous pregnancy loss. MB were also measured using formamido-
pyrimidine DNA glycosylase to convert them into strand breaks.
results: In IVF, FR and ECS decreased as DF increased in both semen and DGC sperm, and couples who failed to achieve a CP had
higher DF than successful couples (+12.2% semen, P ¼ 0.004; +9.9% DGC sperm, P ¼ 0.010). When MB were added to existing strand
breaks, total DF was markedly higher (+17.1% semen, P ¼ 0.009 and +13.8% DGC sperm, P ¼ 0.045). DF was not associated with FR, ECS
or CP in either semen or DGC sperm following ISCI. In contrast, by including MB, there was signiﬁcantly more DNA damage (+16.8%
semen, P ¼ 0.008 and +15.5% DGC sperm, P ¼ 0.024) in the group who did not achieve CP.
conclusions: DF can predict ART outcome for IVF. Converting MB into further DNA strand breaks increased the test sensitivity,
giving negative correlations between DF and CP for ICSI as well as IVF.
Key words: Comet assay / formamidopyrimidine DNA glycosylase enzyme / modiﬁed base / sperm DNA fragmentation / threshold
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Introduction
Infertility is becoming a public health issue as birth rates continue in a
sustained decline across Europe. Over the last 50 years, they have
plummeted to reach an unprecedented low of 1.4 children per
couple (Commission of the European Communities, 2009). In 2008,
the European Parliament (2008) acknowledged for the ﬁrst time that
falling birth rates were a major cause of its population decline. Over
mortality and migration, small family size is the major determinant of
the future population number and composition in Europe (Maccheroni,
2007). Infertility affects one in six couples of childbearing age (Hull et al.,
1985), and male problems are responsible for 40% of these cases
(Fleming et al., 1995). One solution to the problem of reduced birth
rates is to lessen the decline through the use of assisted reproduction
technology (ART). Europe already performs 60% of all ART treat-
ments in the world (Nygren and Andersen, 2001) and in European
countries between 1% and 6% (Andersen and Erb, 2006; RAND,
2006) of the births are currently aided by ART. Hence, ART has the
potential to signiﬁcantly inﬂuence adverse economic and demographic
factors, and the European parliament has ﬁnally recognized that inferti-
lity treatment should be incorporated into the proposed population
policy mix (European Parliament, 2008; Ziebe and Devroey, 2008).
The European Parliament (resolution adopted by Parliament on 21
February 2008) calls on Member States to ensure the right of couples
to universal access to infertility treatment. If implemented, this would
be a major step forward since the majority of provision for infertility
is currently in the private sector (except in Scandinavia and Belgium)
with only those who can afford it having access to such services.
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The next step forward is for clinicians to accept the need for, and
scientists to work in partnership to devise, novel diagnostic and prog-
nostic tests to improve the relatively modest ART success rates. Mean
European ‘take-home baby’ rates still have room for improvement as
they are 30.1% (Andersen et al., 2008) compared with 27.0% a
decade ago (Land and Evers, 2003), although some countries are
more successful than others (Van den Bergh et al., 2006). The UK
national live birth rate for fresh cycles to women less than 35 years
is 32.3% (Human Fertilization and Embryology Authority, 2003,
2007), although it was lower in 2000 (21.8%). If ART is to be included
as a substantial part of the new population policy, there will need to be
government-led and -funded demands for improvement of ART
success rates. Male infertility has been long neglected and this is the
area where most rapid progress could be made. However, this will
force ART personnel to re-examine the assessment of male fertility
potential and agree on improved prognostic sperm function tests
with clinical relevance for each type of ART treatment.
Conventional semen analysis by light microscopic assessment of
semen parameters (semen volume, sperm count, motility and mor-
phology) is now recognized to be of limited value in the determination
of the couples’ fertility status (reviewed by Lewis, 2007). In contrast,
sperm DNA testing has been increasingly recognized as a more prom-
ising test (Aitken and de Iuliis, 2007; Evenson et al., 2007; Zini et al.,
2008). Measurement of sperm DNA damage is a useful biomarker for
infertility with numerous studies showing its association with longer
times to conceive compared with fertile couples (Spano et al.,
2000), impaired embryo cleavage (Morris et al., 2002), higher miscar-
riage rates (Evenson et al., 1999) and also a signiﬁcantly increased risk
of pregnancy loss after IVF and ICSI (Zini et al., 2008). However, the
implications of sperm DNA damage are even farther reaching. As
sperm have few repair mechanisms (Jansen et al., 2001; Olsen et al.,
2003; Aitken and Baker, 2006) and oocytes can only repair limited
amount of damage (Ahmadi and Ng, 1999; Derijck et al., 2008), the
damage to sperm DNA may affect the germ line for generations
(Aitken and de Iuliis, 2007). Of even more concern than its ability
to reduce fertility is the knowledge that sperm with oxidative DNA
damage may still retain the potential to reach the oocyte, achieve fer-
tilization and thereby contribute to mutations during embryonic devel-
opment (Fraga et al., 1991) or even to loss of the fetus. If damaged
sperm DNA is incorporated into the embryonic genome, it may
lead to errors in DNA replication, transcription and translation
during embryogenesis, contributing to a number of human diseases
(Cooke et al., 2003) in not just one but subsequent generations
(reviewed by Aitken et al., 2008). In particular, sperm DNA can
impact on the short- and long-term health of children born by ART.
Children conceived by ART, particularly ICSI, have a higher incidence
of disease than those conceived spontaneously (Basatemur and Sut-
cliffe, 2008).Continuing into childhood, there is a strong association
between poor sperm DNA integrity and diseases ranging from child-
hood cancers and leukaemias to autism (reviewed by Aitken and de
Iuliis, 2007), especially aggravated by paternal smoking (Ji et al.,
1997; Sorahan et al., 1997). A number of studies have shown major
congenital malformations are present in 10% of ICSI children com-
pared with 3% in spontaneously conceived counterparts (Lie et al.,
2005; Sutcliffe and Ludwig, 2007; Katari et al., 2009; Williams and
Sutcliffe, 2009; Woldringh et al., 2010), whereas other reviews
suggest little difference in the health of the two groups (Ludwig
et al., 2006). There is controversy surrounding the assessment and
clinical value of DNA assessments; however, despite the current con-
ﬂict in the literature (Barratt et al., 2010: Sakkas and Alvarez, 2010),
studies are rapidly accumulating (reviewed by Aitken et al., 2008) to
show that the link is through DNA damage to the father’s sperm
and that DNA damage is higher in ICSI patients (Bungum et al.,
2007). Although there is much evidence associated with sperm
DNA damage and poor ART outcomes, the tests have not been
brought into clinical use.
Clinical thresholds to predict the chance of sperm populations
achieving a clinical pregnancy (CP) have been established for the
sperm chromatin structure assay (SCSA) (Bungum et al., 2007,
reviewed by Evenson et al., 1999). A number of recent studies also
show inverse relationships between fertility outcomes and DNA frag-
mentation (DF) using the terminal deoxynucleotidyl-transferase-
mediated dUTP nick-end labelling assay (TUNEL; Spano et al., 2000;
Henkel et al., 2004; Tesarik et al., 2004). As yet, there are no clinical
thresholds for the Comet assay (Lewis et al., 2004), although it is
recognized to be more sensitive than other DNA damage tests
(Leroy et al., 1996; Irvine et al., 2000) and is the only technique that
allows the measurement of DNA damage in individual cells; particu-
larly useful in a heterogeneous population such as sperm. The
Comet assay measures both single- and double-strand DNA breaks
using an alkaline pH method (Hughes et al., 1996; Donnelly et al.,
2001). The Comet assay is highly reproducible (Hughes et al., 1997)
and as it requires a much smaller number of cells (Hughes et al.,
1996) for analysis than other tests, it is suitable for measures of testi-
cular and oligozoospermic sperm samples where cells are scarce.
Oxidative stress (OS) has long been implicated as the major aetio-
logical factor in sperm DNA damage. A low physiological level of reac-
tive oxygen species (ROS) is accepted as necessary to maintain normal
sperm function (Agarwal et al., 2003) but if ROS levels exceed phys-
iological norms they lead to deteriorating function or reduced survival
(Aitken and Baker, 2002). In contrast to somatic cells, sperm are very
vulnerable to OS (Sies et al., 1992; Sies, 1993) owing to their unique
membrane structures combined with limited antioxidants (Lewis et al.,
1995) or protective enzymes. Not only does OS cause strand breaks
but it also instigates deoxyribose damage, loss of bases or modiﬁ-
cations to bases, such as 7,8-dihydro-8-oxo-2′-deoxoguanosine
(8-OHdG), a modiﬁed base (MB) of the purine guanosine (Croteau
and Bohr, 1997). Furthermore, such base modiﬁcations may also
lead to discrete DNA strand breaks (Croteau and Bohr, 1997). Of
the numerous oxidative MB (Croteau and Bohr, 1997), 8-OHdG is
one of the most abundant and readily studied. Compared with
other cell types, sperm exhibit much greater oxidative DNA damage
as measured by 8-OHdG, 1025 dG (Kodama et al., 1997), and
higher levels of 8-OHdG have been observed in sperm from infertile
compared with healthy subjects (Kodama et al., 1997; Shen et al.,
1999) as well as an inverse correlation between sperm counts and
8-OHdG (Kodama et al., 1997; Ni et al., 1997; Shen et al., 1999;
Xu et al., 2003). Therefore, the measurement of MB combined with
DF assays gives an insight into potential, as well as existing, DF and
may prove to enhance the prognostic usefulness of the current test.
In this study, we have used the alkaline Comet assay with and
without the addition of formamidopyrimidine DNA glycosylase
(FPG). This is a bifunctional DNA glycosylase recognizing oxidated
purines, such as 8-OHdG, thereby converting MB into strand breaks
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which can be measured by the Comet assay (Collins, 2004). In order
to determine both actual and potential DNA damage, we used
Comet+ FPG and assessed its usefulness as a prognostic test.
Materials and Methods
Subjects
Men attending the Regional Fertility Centre, Royal Jubilee Maternity Service,
Belfast, for infertility treatment between March 2008 and September
2009 were invited to participate in this study [n ¼ 230 from IVF, mean
(+SD) age 37.2+0.3 years and n ¼ 130 from ICSI, mean age 37.0+ 0.5
years]. All subjects gave written informed consent for participation in this
study, and the project was approved by the Ofﬁce for Research Ethics
Committees in Northern Ireland and the Royal Group Hospitals Trust
Clinical Governance Committee. Semen samples were obtained after a
recommended 2–5 days of sexual abstinence. All samples were subjected
to a conventional light microscopic semen analysis to determine liquefaction,
semen volume, sperm concentration, total sperm output and motility
according to World Health Organization (WHO) recommendations
(WHO, 1999). Sperm morphology was assessed according to WHO
(1992) criteria. Semen analysis was performed within 1 h of ejaculation,
following a period of incubation at 378C to allow for liquefaction. After
liquefaction, routine semen analyses were performed and subsequently
semen was puriﬁed by density gradient centrifugation (DGC) using a
two-step discontinuous Puresperm gradient (90–45%; Hunter Scientiﬁc
Limited, UK). For each semen sample with a normozoospermic proﬁle,
the whole sample was layered on the top of 2 ml (90%) and 4 ml (45%)
gradient and centrifuged at 250g for 20 min. For semen samples with less
than normal WHO parameters, 1 ml of semen was layered on the top of
1 ml (90%) and 1 ml (45%) gradient and centrifuged at 100g for 20 min.
The resulting sperm pellets were washed twice with Vitrolife G5 culture
media (Vitrolife Inc., Goteborg, Sweden) and concentrated by centrifugation
at 250g (normozoospermic) and 100g (subnormal) for 10 min and resus-
pended in fresh culture media (2 ml). Hence, two populations of sperm
for each patient were used to measure DNA damage by the Comet assay
that with the best fertilizing potential as used for their clinical treatments
(DGC sperm) and the whole population (native semen).
ART procedures
All IVF cycles were performed according to the routine procedures
(Donnelly et al., 1998). Brieﬂy, ovulation induction was achieved with
recombinant FSH following a long protocol of pituitary desensitization
with a GnRH analogue. HCG was administered when there were at
least four follicles of diameter .17 mm, 36 h before oocyte retrieval.
Mature, metaphase II oocytes obtained by vaginal ultrasound-guided
aspiration were cultured in media [Vitrolife G5 sequential media series
(Vitrolife Inc.)] at 378C with 6% CO2 in air. The ICSI procedure has
been described in detail previously (Van Steirteghem et al., 1993). In
brief, a suspension of washed sperm was placed in polyvinylpyrrolidone
(Vitrolife Inc.) and a free, motile sperm immobilized. The sperm was
aspirated into the injection pipette tail-ﬁrst and injected into an oocyte.
Fertilization was recorded 12–16 h after injection. In each case, one or
two embryos were transferred into the uterine cavity after an additional
24–48 h. Luteal phase support was provided by vaginally administered
progesterone. An intrauterine pregnancy with fetal heart beat was
conﬁrmed by ultrasound 5 weeks after embryo transfer.
Single-cell gel electrophoresis (Comet) assay
Nuclear DF was assessed using an alkaline single-cell gel electrophoresis
(Comet) assay as modiﬁed previously by our group (Hughes et al.,
1997; Donnelly et al., 1999). Our previous study has reported an
intra-assay coefﬁcient variation of 6% for this assay (Hughes et al., 1997).
FPG treatment
Of the MB, 8-OHdG is the most commonly studied biomarker and is often
selected as being representative of oxidative DNA damage owing to its
high speciﬁcity, potent mutagenicity and relative abundance in DNA
(Floyd, 1990). We used the protein FPG, a bacterial repair enzyme
isolated from Escherichia coli, which recognizes and excises 8-OHdG
generated by ROS. The FPG enzyme extract was puriﬁed from E. coli
ER 2566 strain harbouring the pFPG230 plasmid, as described previously
(Boiteux et al., 1990; Olsen et al., 2003). The extract has been shown
to possess afﬁnities towards the various DNA base modiﬁcations known
to be recognized by pure FPG (Dr S. Sauvaigo, personal communication).
The catalytic activity of FPG involves a three-step process: (i) hydrolysis of
the glycosidic bond between the damaged base and the deoxyribose,
(ii) incision of DNA at basic sites leaving a gap at the 3′- and 5′-ends by
phosphoryl groups and (iii) removal of terminal deoxyribose 5′-phosphate
from 5′-terminal site to excise the damaged base, as shown by Kuznetsov
et al. (1998). To analyse MB, FPG (stock concentration of 19.14 mg/ml,
diluted to a ﬁnal concentration of 1 mg/ml) was added to sperm to
introduce breaks at sites of MB during decondensation by lithium
3,5-diiodosalicylate and incubated at 37.08C for 90 min. Our previous
study (Hughes et al., 1997) showed an intra-assay coefﬁcient variation of
6% for the Comet assay. The overall SEM for all IVF/ICSI samples in this
study without FPG is low (4%) and is not increased by FPG, suggesting
that variation linked to the addition of FPG is of minor importance.
Data and statistical analysis
Data were analysed using the Statistical Package for the Social Sciences
(SPSS 15) for Windows (SPSS Inc., Chicago, IL, USA). Demographic
details of couples are given in Table I according to the treatment (IVF or
ICSI) and outcome. Our primary outcome for each treatment was the
effect of DNA damage (analysed by Comet+ FPG) on CP, evaluated in
both native semen and DCG sperm by logistic regression. The key
outcome from the model derived above is individual posterior probabilities
of a positive CP. We tested the performance of our prognostic model by
calculating the c-statistic, which is identical to the area under the receiver
operating characteristic (ROC) curve. Essentially, all possible pairs of individ-
uals where one is pregnant and one is not pregnant were considered. Then,
the number of such pairs where the posterior probability for the pregnant
couple is higher than the posterior probability for the non-pregnant couple
was counted: this was deﬁned as the c-statistic. A null performance of the
model would result in a c-statistic of 0.5.
Secondary outcomes were fertilization rate (FR) and embryo cumulative
score (ECS). The FR was calculated as the percentage of all fertilized
oocytes for IVF, and the percentage of metaphase II oocytes with two pro-
nuclei for ICSI. The ECS was calculated for 153 couples who had embryo
transfers on Day 3, by multiplying embryo grade (A ¼ 4, B ¼ 3, C ¼ 2 and
D ¼ 1) by the number of blastomeres for each embryo and where a
patient had more than one embryo, a mean across embryos was calcu-
lated to obtain the total quality of all embryos generated (ECS1) or
embryos transferred (ECS2). Use of ECS, as opposed to number of high-
quality embryos, allows for quantiﬁcation of the number and quality of
blastomeres, making associations more precise. Relationships between
sperm DF and the FR and ECS were compared using the Spearman
rank correlation test. Associations between conventional semen param-
eters and DF and MB were also assessed using the Spearman rank
correlation test. To determine the extent of damage contributed by MB,
we compared existing DNA strand breaks with total strand breaks
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Table I Demographic data for couples undergoing ARTs.
IVF (n 5 230) ICSI (n 5 130)
Pregnant Non-pregnant CI P-value Pregnant Non-pregnant CI P-value
Cycles included (n) 39 180 — — 34 82 — —
Female age (years) 34.4+4.3 37.5+5.7 211.3 to 5.1 NS 34.9+3.7 34.9+5.2 21.9 to 1.9 NS
Number of previous treatments 1.5+0.9 1.4+1.2 20.4 to 0.5 NS 1.8+0.9 1.7+1.0 20.4 to 0.5 NS
Oocytes retrieved 10.5+6.4 8.2+5.2 0.4–4.2 0.021 10.2+5.0 8.1+4.9 0.3–4.0 NS
Oocytes fertilized (2 pronuclei) 6.9+3.9 4.9+4.0 0.7–3.5 0.004 6.7+3.8 8.5+3.2 20.1 to 2.5 NS
Fertilization rate (%) 72.6+20.6 62.5+31.2 20.5 to 20.7 0.062 77.6+20.5 79.7+18.4 210.1 to 5.8 NS
Embryos transferred 1.9+0.2 1.6+0.7 0.1–0.6 0.013 1.9+0.4 1.8+0.4 20.1 to 0.2 NS
Total embryo cumulative score (ECS1) 18.1+10.9 13.3+9.3 0.9–7.1 0.012 12.0+5.5 11.4+4.9 21.6 to 3.0 NS
Transferred embryo cumulative score (ECS2) 43.8+17.8 31.0+12.5 4.5–19.9 0.002 51.1+2.5 42.2+2.3 0.3–13.7 0.049
Male age (years) 36.1+4.9 37.4+5.0 23.1 to 0.4 NS 38.3+4.6 36.4+4.9 0.01–3.8 NS
Semen volume (ml) 3.1+1.4 3.5+2.4 21.2 to 0.4 NS 3.4+2.2 3.6+2.8 21.3 to 0.9 NS
Sperm concentration (106 ml21) 63.7+36.0 67.4+40.7 217.9 to 10.5 NS 42.3+49.1 30.6+34.0 25.8 to 29.2 NS
Total sperm output (106) 199.3+143.2 233.6+392.5 2183.6 to 75.1 NS 157.5+220.8 115.5+148.4 237.4 to 121.4 NS
Motility (%) 56.1+20.9 54.8+17.1 25.1 to 7.7 NS 45.9+21.0 43.8+22.3 27.5 to 11.7 NS
Normal morphology (%) 28.5+15.2 24.7+9.4 20.01 to 7.6 0.05 20.4+9.9 18.1+11.2 22.4 to 6.9 NS
Values are the mean+ SD. NS, non-signiﬁcant; CI, 95% conﬁdence interval.
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(i.e. including converted MB) using a paired sample t-test. A P-value ,0.05
was considered statistically signiﬁcant.
To compare the prognostic ability of the different sperm DNA damage
variables, we ran logistic regression models with pregnancy (yes/no) as
outcome and with each of four DNA damagemarkers individually as explana-
tory variables: the markers were DFmeasured by the alkaline Comet assay in
native semen and in populations of sperm following DGC, with and without
the addition ofMB.Weused the 230 IVF cycles to determine thresholds ofDF
(not includingMB) in native andDCG sperm. Predicted probabilities of a preg-
nancy were obtained to achieve CP with 80% power. From these, we esti-
mated thresholds where the predicted probability of a positive pregnancy
was equal to 0.1 (ED10). Odds ratios (ORs) and their 95% conﬁdence inter-
vals (CIs) were computed based on these threshold values. Sensitivities and
speciﬁcities were calculated above and below the threshold values, together
with the ROC and 95% CI for ROC. Separate models were constructed for
IVF and ICSI treatment groups. CIs for ROC, which include the value 0.5, are
statistically indistinguishable.
Results
Comparison of conventional semen proﬁles
from couples who achieved a pregnancy
compared with couples who were
unsuccessful following ART
Semen samples from couples who achieved a CP were compared with
those who were unsuccessful (Table I). Abstinence times did not differ
between the groups. No signiﬁcant differences were observed in
semen volume, sperm concentration, total sperm output and percen-
tage motility.
Correlations between DF, FR and embryo
quality assessed by the alkaline Comet assay
following IVF treatment
There was no decrease in FR as DNA damage of native semen
increased (data not shown, P. 0.05). In contrast, there was a
decrease in FR as sperm DF increased in DGC sperm: 0–20% and
21–40% DF were associated with higher FR (69.9+3.7% and
66.4+4.2%, respectively) compared with an FR of 54.4+6.0%
when DNA damage was 61–100% in DGC sperm (P, 0.05,
Fig. 1). There was also a decrease in ECS as DF increased, both in
native semen and in DGC sperm. The cumulative embryo score
(ECS1) for all the embryos generated showed a signiﬁcant decrease,
when DNA damage was greater than 60% in the native semen. The
ESC1 was 15.5+2.6% in the group where sperm DF was 0–20%
reducing to 10.7+1.5% in the group where DF was 61–100%
(P ¼ 0.020) in the native semen. The ECS1 was only 7.3+2.5%
where sperm DF was 61–100% in DGC sperm (P ¼ 0.032; Fig. 2).
Similarly, the ECS2 showed a decrease when DF was greater than
60% compared with that below 20% DNA damage (38.1+6.6 and
26.7+3.8, respectively, P ¼ 0.007) in the native semen and
(18.7+5.9 and 34.1+ 3.60, respectively, P ¼ 0.034; Fig. 3) in the
DGC sperm. Pregnant couples had higher mean ECS1 (P ¼ 0.012)
and ECS2 (P ¼ 0.002) than non-pregnant couples (Table I). There
was a correlation between FR and sperm motility (P ¼ 0.014) but
no signiﬁcant correlations were seen between any other semen
parameter and FR, ECS1, ECS2 or CP.
Sperm DF of pregnant and non-pregnant
couples following IVF
Using the Comet assay, the mean percentage of sperm DF was signiﬁ-
cantly higher in sperm from non-pregnant couples (n ¼ 180) com-
pared with that from pregnant couples (n ¼ 39) undergoing IVF in
both the native semen (51.7+ 23.6 versus 39.5+17.9; P ¼ 0.004)
and the DGC sperm for clinical use (36.8+21.6 versus 26.9+
14.6; P ¼ 0.01) (Table II). Using the threshold values of 56% for the
native semen and 44% for the DGC sperm, we calculated OR and
CI of 4.52 (1.79–11.92) and 6.20 (1.74–26.30), respectively, for CP
(Fig. 4; Tables III and IV).
Sperm DF, FR, embryo quality and
pregnancies following ICSI treatment
The ECS2 had a signiﬁcantly higher score for pregnant couples (51.1+
2.5) than non-pregnant couples (42.2+ 2.3; P ¼ 0.049). Sperm
Figure 1 Bar chart showing decrease in fertilization rate (FR) with increase in DNA damage in the sperm prepared using DGC (sperm), for patients
undergoing IVF. Values are mean+ SEM, *P, 0.05, n ¼ 222.
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from partners of couples undergoing ICSI who failed to achieve a CP
tended to have more DF than sperm from pregnant couples (net
increase of +8.3% native semen, P ¼ 0.109 and +6.2% DGC
sperm, P ¼ 0.243) (Table II). There was no correlation between
sperm DNA damage and FR, or ECS1 or ECS2.
The relationship between total DNA damage
and IVF and ICSI outcomes after conversion
of MB to DNA strand breaks by FPG
A signiﬁcant increase in DNA damage was detected after treatment
with the DNA glycosylase FPG in both native and DGC samples
(P, 0.0001; Table V). The variation in damage (with FPG) ranged
from 0% to 47% in the native and 0% to 45% in the DGC sperm.
In the IVF patients, addition of the FPG enzyme showed a signiﬁcant
increase in DF in sperm from non-pregnant (n ¼ 63) compared
with that from pregnant couples (n ¼ 10) in the native semen (with
a net increase of +17.1%; P ¼ 0.009) and in the DGC sperm (a
net increase of +13.8%; P ¼ 0.045) (Table II). Similarly, in ICSI
couples, when MB were included, the DNA damage between
pregnant and non-pregnant couples was markedly different (with a
net increase of +16.8% native semen, P ¼ 0.008 and +15.5%
DGC sperm, P ¼ 0.024) in contrast to Comet without FPG, where
there was no signiﬁcance (Table II).
The prognostic value of DNA damage (strand breaks plus adducts)
testing
We tested the performance of our prognostic model by calculating
the area under the ROC curve (Table II). Essentially, all possible
pairs of individuals where one is pregnant and one is not pregnant
Figure 2 Bar chart showing decrease in cumulative embryo score of total embryos generated with increase in DNA damage in the DGC sperm, for
patients undergoing IVF. Values are mean+ SEM, *P, 0.05, n ¼ 153.
Figure 3 Bar chart showing decrease in cumulative embryo score of transferred embryos with increase in DNA damage in the DGC sperm, for
patients undergoing IVF. Values are mean+ SEM, *P, 0.05, n ¼ 153.
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............................................................................................................... .....................................................................................................................
..........................................................................................................................................................................................................................................................
Table II Comparison of DF between pregnant and non-pregnant couples after IVF and ICSI treatments.
IVF ICSI
Pregnant
couples
Non-pregnant
couples
Difference (95%
CI)
P-value ROC (95% CI) Pregnant
couples
Non-pregnant
couples
Difference (95%
CI)
P-value ROC (95% CI)
n 39 180 — — — 34 82 — — —
DF in
native
semen (%)
39.5+17.9 51.7+23.6 12.2 (215.9, 24.0) 0.004 0.648 (0.561, 0.735) 58.9+25.7 67.2+25.6 8.3 (218.5, 1.9) 0.109 0.601 (0.488, 0.713)
DF in
DGC
sperm (%)
26.9+14.6 36.8+21.6 9.9 (217.5, 22.4) 0.010 0.629 (0.542, 0.717) 45.5+24.5 51.7+27.0 6.2 (216.7, 4.2) 0.243 0.572 (0.461, 0.683)
n 10 63 — — — 15 38 — — —
DF in
native
semen
after FPG
treatment
(%)
54.7+4.9 71.8+19.1 17.1 (229.7, 24.4) 0.009 0.776 (0.643, 0.910) 63.1+23.6 79.9+18.7 16.8 (229.2, 24.6) 0.008 0.704 (0.537, 0.872)
DF in
DGC
sperm
after FPG
treatment
(%)
42.2+6.5 56.0+19.9 13.8 (227.4, 20.3) 0.045 0.693 (0.524, 0.862) 50.0+22.2 65.5+21.7 15.5 (228.9, 22.1) 0.024 0.717 (0.555, 0.878)
Values are expressed as the mean+ SD. ROC, receiver operating characteristic (area under, cm2); DGC, density gradient centrifugation; FPG, formamidopyrimidine DNA glycosylase enzyme.
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were considered. The analysis for IVF CP showed the area under the
curve is 0.648 cm2 (P ¼ 0.006) for the native semen and 0.629 cm2
(P ¼ 0.016) for the DGC sperm from pregnant compared with non-
pregnant couples, respectively. When MB were included the area
under the ROC curve increased to 0.776 cm2 (P ¼ 0.005) for the
native semen and 0.693 cm2 (P ¼ 0.05) for the DGC sperm. In the
ICSI group, for total DNA damage (including MB), a signiﬁcant differ-
ence was observed between pregnant and non-pregnant couples. The
ROC analysis for ICSI when MB were included also increased the area
under the ROC curve in both the native semen and the DGC sample
Figure 4 Scatter plot showing DNA fragmentation (DF) measured by Comet in the native and DGC sperm according to their pregnancy outcome in
IVF. n ¼ 219.
.................................................................. ...........................................................
.............................................................................................................................................................................................
Table IV OR on ART outcome in IVF and ICSI cycles using a cut-off value of 44% in the DGC sperm.
IVF ICSI
<44% >44% OR (95% CI) <44% >44% OR (95% CI)
Cycles started 158 66 — 54 72 —
Biochemical pregnancies (n, % per cycle) 51 (32.3) 11 (16.6) 2.32 (1.07–5.14) 25 (46.3) 26 (36.1) 1.53 (0.70–3.34)
Clinical pregnancies (n, % per cycle) 36 (22.8) 3 (4.5) 6.20 (1.74–26.30) 24 (44.4) 20 (27.8) 2.08 (0.93–4.68)
Deliveries to date (n, % per cycle) 28 (17.7) 1 (1.5) 57.00 (3.47–1794.29) 19 (35.2) 9 (12.5) 0.90 (0.22–3.61)
Early pregnancy loss (n, % per cycle) 2 (1.3) 2 (3.0) 84.00 (2.89–14 248.30) 4 (7.4) 4 (5.6) 2.38 (0.37–15.89)
............................................................... ............................................................
.............................................................................................................................................................................................
Table III OR on ART outcome in IVF and ICSI cycles using a cut-off value of 56% in the native semen.
IVF ICSI
<56% >56% OR (95% CI) <56% >56% OR (95% CI)
Cycles started 127 97 — 47 80 —
Biochemical pregnancies (n, % per cycle) 44 (34.6) 18 (18.6) 2.58 (1.31–5.12) 23 (48.9) 31 (38.8) 1.18 (0.52–2.68)
Clinical pregnancies (n, % per cycle) 32 (25.2) 7 (7.2) 4.52 (1.79–11.92) 20 (42.6) 24 (30.0) 1.97 (0.81–4.77)
Deliveries to date (n, % per cycle) 27 (21.3) 2 (2.1) 10.13 (0.74–294.05) 17 (36.2) 15 (18.8) 5.25 (1.15–25.7)
Early pregnancy loss (n, % per cycle) 2 (1.6) 2 (2.1) 16.5 (0.95–424.73) 3 (6.4) 5 (6.3) 2.95 (0.49–19.16)
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compared with Comet alone, 0.704 cm2 compared with 0.601 cm2
(P ¼ 0.015) and 0.717 cm2 compared with 0.572 cm2 (P ¼ 0.005),
respectively, again indicating the improved prognostic ability with
MB. Measurement of DF in native semen and DGC sperm had a
higher sensitivity but lower speciﬁcity in IVF than ICSI treatment
(Table VI). The threshold value showed a high negative predictive
value (93% and 95%) for IVF CP using both native and DGC sperm,
respectively. The positive predictive value for IVF and ICSI success
with native sperm was less robust, being 27% and 40%, respectively.
Discussion
In this study, the predictive value of sperm DF in native and DCG
sperm on IVF and ICSI outcomes was assessed in a cohort of 360
ART patients using the alkaline Comet assay. The predictive power
was signiﬁcantly increased by using a modiﬁed Comet assay allowing
oxidated purines to be measured, by converting such base modiﬁ-
cations into strand breaks by means of the DNA glycosylase, FPG.
We noted a relationship between existing DF and ART outcomes
(FR, ECS1, ECS2 and CP) in IVF cycles but not in ICSI cycles.
However, when the MB were converted into strand breaks, an
inverse relationship was also observed in ICSI cycles. In the IVF
group, using a threshold value of 56% and 44% DF (for native
semen and DGC sperm, respectively, without FPG treatment),
there was a signiﬁcant decrease in pregnancy rates in the high DF
group.
Male infertility diagnosis is still based on the conventional semen
analysis, despite its prognostic and diagnostic limitations for the infer-
tile couple (reviewed by Tomlinson et al., 1999; Lewis, 2007). Some
studies have shown relationships between DF and sperm concen-
tration (Tomlinson et al., 2001), normal morphology and progressive
motility (Larson-Cook et al., 2003) or the absence of immature
sperm (Virro et al., 2004) in native semen. Our data support those
of Frydman et al. (2008) and Greco et al. (2005) in showing few cor-
relations between conventional semen parameters and DF and is in
conﬂict with the study reported by Irvine et al. (2000) where sperm
DNA damage assessed by the Comet assay was closely associated
with semen quality; in particular with sperm concentration. Here, in
68% of IVF patients, semen proﬁles were normozoospermic according
to the WHO criteria, yet almost half of those men had DF above our
threshold value of 48%. In the ICSI group, 34% had normal semen par-
ameters (these couples had previously had IVF treatment: 47% had
failed fertilization and 53% had not achieved a pregnancy), although
54% had DF above 50%. Thus, no strong relationships were found
between semen analysis parameters and DF. Although conventional
parameters have been shown to have no correlation with ICSI
outcome (Nagy et al., 1995, 1998), these are still the characteristics
by which sperm are chosen clinically, yet in this study we have again
shown that these are not necessarily the sperm with the best DNA.
Since sperm DNA tests show more promise, it is urgent to reﬁne
these tests until they are sufﬁciently robust for routine clinical use.
Sperm DNA damage has been closely associated with numerous
indicators of reproductive health, including FR, ECS, implantation
and spontaneous miscarriage (Lewis and Aitken, 2005; Frydman
et al., 2008) using several techniques to assess sperm DNA damage.
Of these, the Comet assay under alkaline and neutral conditions,
TUNEL assay and SCSA (reviewed by Evenson et al., 2002; Agarwal
and Said, 2003) have been shown to be most robust. Each of these
tests assesses different aspects of DNA damage. The SCSA is based
on partial acid-induced denaturation and staining with acridine
orange, and analysis of the staining pattern of each cell using ﬂow cyto-
metry. On the other hand, TUNEL assay is a direct method for the
assessment of DF, by quantifying the incorporated dUTP at double-
strand DNA breaks catalysed by terminal deoxynucleotidyl transferase
(Martins et al., 2007). The alkaline Comet assay assesses double- and
single-strand DNA breaks and alkali labile sites. It has been used in
vitro and in vivo in a wide variety of mammalian cells (Singh et al.,
1988; Tice et al., 1990; Olive et al., 1998) employing a number of
.............................................................................................................................................................................................
Table V Comparison of DF in the native semen and the DGC sample according to the treatments.
ART treatment n Test Native semen DGC sperm P-value
IVF 230 Comet 49.5+1.6 35.2+1.4 0.0001a
73 Comet + FPG 74.6+2.9 59.8+3.1 0.0001a
P-value ,0.0001b ,0.0001b
ICSI 130 Comet 64.0+2.3 49.1+2.3 0.0001a
53 Comet + FPG 79.4+2.3 54.1+2.4 0.0001a
P-value ,0.0001b ,0.0001b
Values are the mean+ SEM.
aP-value of comparison between native semen and DGC sperm.
bP-value of comparison between Comet and Comet + FPG.
................................. .................................
........................................................................................
Table VI Comparison of cut-off values predicting CP in
the native semen (56%) and the DGC sample (44%).
IVF ICSI
Native (%) DGC (%) Native (%) DGC (%)
Sensitivity 82.1 92.3 47.2 54.6
Speciﬁcity 49.7 34.6 68.8 63.4
PPV 26.7 22.8 40.5 44.4
NPV 92.6 95.5 74.3 72.2
RR 3.6 5.0 1.6 1.6
PPV, positive predictive value; NPV, negative predictive value; RR, relative risk.
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different genotoxic stimuli including UV radiation, carcinogens, radio-
therapy and chemotherapy (Fairbairn et al., 1995). The alkaline
Comet assay is highly reproducible (Hughes et al., 1997) with
greater sensitivity than alkaline elution or nick translation assays
even without prior chromatin decondensation (Leroy et al., 1996;
Irvine et al., 2000). The Comet assay can detect damage equivalent
to as few as 50 single-strand breaks per cell: another of its unique
and powerful features is the ability to characterize the responses of
a heterogeneous population of cells by measuring DNA damage
within individual cells as opposed to just one overall measure of
damaged cells versus undamaged cells, as in the TUNEL. A further
advantage is that, unlike the TUNEL and SCSA which detect primarily
breaks in histone-associated chromatin, the Comet assay has a
broader use in detecting breaks in both protamine and histone-bound
chromatin equally. One drawback of the Comet is that it requires
trained researchers to perform it optimally and results can vary
from lab to lab. Like the SCSA, the Comet assay would beneﬁt
from the standardized protocols and instruction from researchers
who have used it extensively (e.g. those in the Robaire or Lewis
laboratories).
The inﬂuence of DF on FR in assisted reproduction is still controver-
sial since paternal DNA is not believed to inﬂuence this early fertility
checkpoint. In this study, a negative correlation was observed between
sperm DF and FR in both native and DGC sperm. We also observed a
signiﬁcant decrease in FR above 60% DF in native semen. Similarly,
DGC sperm showed a signiﬁcant decrease in FR with increase in DF
(Fig. 1). This is in agreement with a number of studies that show a
marked negative correlation between DF and FR in IVF using the
TUNEL assay (Sun et al., 1997; Host et al., 2000; Benchaib et al.,
2003; Huang et al., 2005; Payne et al., 2005; Borini et al., 2006;
Bakos et al., 2008). Our data do not conﬁrm those of studies using
the SCSA that show no signiﬁcant association of DF with FR (Larson
et al., 2000; Larson-Cook et al., 2003). The adverse effects of DF
seen here may be expected since abnormal chromatin packing in
sperm is associated with high DNA damage (Simon, Lewis and
Oliva, unpublished results) and also with a failure of sperm DNA to
decondense post-fertilization (Sakkas et al., 1996; Lopes et al., 1998).
Our study also showed a negative correlation between DF and the
cumulative embryo score of both ECS1 and ECS2, and this relationship
is true for both native and DGC sperm. A similar association between
sperm DF and poor ECS after IVF was reported by many groups (Host
et al., 2000; Tomsu et al., 2002; Seli et al., 2004; Tesarik et al., 2004;
Virro et al., 2004; Muriel et al., 2006). Our results contrast with those
of studies showing no signiﬁcant association of ECS and DF (Larson
et al., 2000; Larson-Cook et al., 2003; Payne et al., 2005; Benchaib
et al., 2007; Bungum et al., 2007; Bakos et al., 2008; Frydman et al.,
2008). Van Royen et al. (2003) concluded that poor quality blasto-
meres can lead to cleavage stage arrest in vitro and are associated
with a lower implantation rate. The impact of fragmented paternal
DNA became more obvious when the embryonic genome was acti-
vated (Braude et al., 1988) giving the so-called ‘late paternal effect’
(Tesarik et al., 2004). Again this shows promise as a useful clinical bio-
marker since as sperm DNA damage increases, ECS2 decreases and
this is followed by a reduced likelihood of a successful CP ensuing
(Sun et al., 1997; Morris et al., 2002; Tesarik et al., 2004). In contrast,
in the ICSI group, there was no correlation between DF and FR. This is
not surprising because the ICSI technique bypasses the requirement
for sperm to penetrate the oocyte naturally. These data support
studies where FR in ICSI was not inﬂuenced by sperm DF (Borini
et al., 2006; Bungum et al., 2007; Bakos et al., 2008). However,
again the literature is in conﬂict with numerous other studies reporting
an inverse relationship between FR and DF (Lopes et al., 1998; Henkel
et al., 2003; Huang et al., 2005; Payne et al., 2005; Muriel et al., 2006;
Benchaib et al., 2007). Further, we did not observe a correlation
between DF measured by the Comet assay and ECS1 in ICSI cycles.
Our results support the belief that DNA damage in the sperm is
not important at this early stage, since until the 4–8-cell embryonic
stage the oocyte genome controls early development. Only after
this stage does the embryonic genome become transcriptionally
active, with the paternal genome contributing to further embryo
development (Braude et al., 1988).
The transfer of good-quality embryos is a major determinant of CP
rates with IVF and ICSI (Scott, 2003; Terriou et al., 2007). In our study,
sperm DF above 60% was associated with poorer ECS2, and decreas-
ing CP in IVF but not in ICSI treatments. In IVF, successful couples had
a signiﬁcantly higher quality of transferred embryo (ECS2) than unsuc-
cessful couples. However, in ICSI, the ECS2 did not differ following
insemination by sperm with high or low DF. The impact of sperm
DF depends on the extent of damage in the sperm and ability of
the egg to repair that damage (Gandini et al., 2004). It may be that
since the primary reason for these couples’ infertility is deﬁned
sperm problems, their oocytes are normal and are capable of repairing
sperm DNA damage (Bungum et al., 2007; Ozmen et al., 2007). The
age of the female partner has long been recognized as a signiﬁcant
factor in a couples’ fertility. It inﬂuences pregnancy rates after vasect-
omy reversal (Gerrard et al., 2007), treatment of male infertility by
ICSI and even the treatment of azoospermia by ICSI with surgically
retrieved sperm (Silber et al., 1997). However, the data here are
not an age-related phenomenon, as the ages of successful and unsuc-
cessful women in both IVF and ICSI were similar (Table I). Another
possibility is that laboratory conditions for sperm during ICSI are
less deleterious than those for IVF. During ICSI, the sperm spend
less time in culture media (Bungum et al., 2007) before injection
into the protected environment of the oocyte and may therefore
have less exposure to further oxidative damage that can occur in
vitro (Dalzell et al., 2003; Agarwal et al., 2006). This possibility is sup-
ported by our data, where the addition of oxidative DNA damage, as
indicated by converted MB, signiﬁcantly enhances the value of the test
for determining pregnancy end-points. Another option is that long
periods in culture media (as more often occur in IVF) may lead to
imprinting defects (Gosden et al., 2003) which could in turn impact
adversely on CP rates. Since our knowledge is currently so limited
as to which types of sperm DNA damage are irreparable and deleter-
ious to reproduction, we can only speculate on this issue.
In our study, couples undergoing IVF had lower DF than those
couples undergoing ICSI (26.9+14.6% versus 45.5+24.5%, respect-
ively) and attained successful CP (Table II). In IVF, DF had a signiﬁcant
deleterious impact on CP (Larson et al., 2000; Tomlinson et al., 2001;
Duran et al., 2002; Larson-Cook et al., 2003; Saleh et al., 2003; Virro
et al., 2004; Frydman et al., 2008). In contrast to our study, others
have found no correlation between DF and CP (Host et al., 2000;
Morris et al., 2002; Tomsu et al., 2002; Benchaib et al., 2003,
2007; Gandini et al., 2004; Huang et al., 2005; Payne et al., 2005;
Boe-Hansen et al., 2006; Borini et al., 2006; Muriel et al., 2006.,
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Bakos et al., 2008; Lin et al., 2008). These differences in results may be
arise from variations in the assay conditions and author imposed
threshold values. The threshold level for TUNEL assay varies
between 4% (Host et al., 2000; Huang et al., 2005), 10% (Borini
et al., 2006), 15% (Benchaib et al., 2007), 20% (Benchaib et al.,
2003; Seli et al., 2004) and 35% (Frydman et al., 2008) and for
SCSA, 20% (Boe-Hansen et al., 2006), 27% (Larson et al., 2000;
Larson-Cook et al., 2003) and 30% (Evenson et al., 1999; Virro
et al., 2004; Payne et al., 2005; Zini et al., 2005), which illustrates
that there are no standardized laboratory protocols for TUNEL
assay. The clinical usefulness of a test is usually based on OR which
in turn are based on threshold values which vary enormously
(Collins et al., 2008) depending on the assay, preparation and scientiﬁc
choice. The threshold value most commonly used is that drawn from a
study by Evenson et al. (1999) where 165 presumed fertile couples,
none with .30% DNA damage, achieved a CP and the conclusion
was therefore that .30% DF was a threshold not considered compa-
tible with fertility. However, this threshold may or may not be appro-
priate for couples undergoing IVF or ICSI and may differ for sperm
from native and DGC populations. In this study, two threshold
values have been used to calculate ORs, 56% for native sperm and
44% for the DGC sperm. These high values (relative to the SCSA
and TUNEL) are related to the sensitivity of the Comet assay in
that following lysis and decondensation, all double- and single-strand
breaks and alkali labile sites are revealed in contrast to other assays
where perhaps only peripheral DNA damage is determined. As viabi-
lity testing is not included in our standard semen analysis, another
reason for the high threshold for native sperm may be the inclusion
of some non-viable cells.
In ICSI cycles, in contrast to IVF, we did not obtain a signiﬁcant
association between DF of native or DGC sperm and CP using the
Comet assay without FPG (Table II), which is in agreement with
many studies (Host et al., 2000; Morris et al., 2002; Benchaib et al.,
2003, 2007; Bungum et al., 2004, 2007; Gandini et al., 2004; Greco
et al., 2005; Huang et al., 2005; Payne et al., 2005; Zini et al., 2005;
Boe-Hansen et al., 2006; Muriel et al., 2006; Lin et al., 2008). As
before, the literature is divided and, in contrast to our results, there
are also studies showing a signiﬁcant decrease in CP with increase in
DF (Larson et al., 2000; Larson-Cook et al., 2003; Saleh et al., 2003;
Virro et al., 2004; Borini et al., 2006; Bakos et al., 2008; Bungum
et al., 2008). However, our data support the hypothesis that ICSI is
able to compensate for existing DNA strand breaks as well as
inadequate conventional sperm parameters (Ozmen et al., 2007;
Bungum et al., 2008).
A major cause of sperm DNA damage is OS, caused by the gener-
ation of the ROS from contaminating leucocytes, defective sperm and
antioxidant depletion (Lewis et al., 1995; Garrido et al., 2004). In
addition to damage caused by creating strand breaks, we measured,
for the ﬁrst time, additional oxidative damage by excising MB to
make them measurable by the Comet assay. When we converted
oxidized purines into strand breaks in both IVF and ICSI couples
(n ¼ 126), an increase in damage of 15.9+1.3% was observed in
native semen and 16.7+1.4% in DGC sperm. By including MB, a
strong association emerged between DF and CP rates in ICSI as
well as increasing the sensitivity of detection in IVF. This shows the
importance of including MB in potential prognostic tests for male infer-
tility rather than focusing on existing strand breaks alone. Earlier
studies had reported that in the measurement of MB (Horak et al.,
2003a), 8-OHdG (Ni et al., 1997) is an important biomarker to inves-
tigate DNA damage and human infertility. MB are also known to
increase in embryos of smoking couples (Zenzes et al., 1999).
Recently, Horak et al. (2007) reported that sperm MB impairs FR
during ICSI. Horak et al. (2003a) showed fertile individuals and
patients with male-factor infertility differed signiﬁcantly with respect
to the level of bulky MB. A signiﬁcant negative correlation is obtained
between MB (Horak et al., 2003b), 8-OHdG (Ni et al., 1997) and
semen quality in patients with an impaired fertility. Horak et al.
(2003b) showed the level of bulky MB in sperm is positively associated
with amounts of leucocytes in semen and also higher in semen of infer-
tile subjects. By measuring both the DNA strand breaks and the FPG
sensitive sites in human sperm, we increased the prognostic value of
the Comet test. Since this study shows that a signiﬁcant proportion
of DNA damage is speciﬁcally a result of OS, it highlights the possibility
of antioxidant therapy to protect sperm DNA prior to ART
treatment.
Given the rigorous sperm selection that occurs naturally and repeat-
edly prior to fertilization (reviewed by Oehninger, 2000), and learning
from the elegant studies of Harrison (1998) that a small minority of
the unselected sperm population in semen may be normal by each
assessment, it is important to examine subpopulations as well as the
whole sperm population of the ejaculate. There is debate as to
whether DGC isolates a subpopulation of sperm with less DF: this
study supports previous work by our group (Donnelly et al., 2000)
and also a report from Morrell et al. (2004) that this is indeed the
case. The fragmentation (both with and without conversion of MB) of
post-DGC was reduced by 10–20% (Table II). However, several
studies report no differences in DNA damage in native and DGC popu-
lations (Stevanato et al., 2008; Thomson et al., 2009). As isolation of
superior subpopulations has been shown to give higher ART success
rates, so a clinical test for this population is needed. Density centrifu-
gation isolates sperm with not only good functional parameters
(WHO, 1999) but also better quality nuclear and mitochondrial DNA
(Donnelly et al., 2000). Surprisingly, the SCSA appears only to be a
useful prognostic tool for native semen (Larson et al., 2000; Bungum
et al., 2008). Using the Comet assay to determine sperm DNA
damage extends its usefulness to DGC populations as well as increasing
its sensitivity.
Two recent systematic reviews have shown that the impact of
sperm DNA damage on ART outcomes decreases from intrauterine
insemination to IVF and is least useful in ICSI (Collins et al., 2008;
Zini and Sigman, 2009), whereas in IVF, using TUNEL and SCSA
assays, the OR is 1.57 (95% CI: 1.18–2.07; P, 0.05). In our study,
using DNA strand breaks only, an OR of 4.52 (1.79–11.92) in the
native semen and 6.20 (1.74–26.30) in the DGC sperm for CP follow-
ing IVF indicates its promise as a prognostic test. Owing to the high
levels of damage observed when both strand breaks and MB were
measured, it was not possible to establish thresholds for this com-
bined test. The OR for CP following ISCI is 1.97 (0.81–4.77) in the
native semen and 2.08 (0.93–4.68) in the DGC sperm showing less
robustness and supporting the combined OR of 1.14 from other
studies reported by Collins et al. (2008) and Zini and Sigman
(2009). This supports the belief that ICSI bypasses genetic, as well
as functional defects, but is difﬁcult to explain. The conclusion is
even more surprising given that all ICSI studies in the current literature
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exclude the patients’ poorest samples; the 10% that are oligoasthe-
noteratozoospermic as they have no sperm surplus to their clinical
requirements. This creates a bias since this group has the beneﬁt of
assisted penetration through the ISCI procedure but with relatively
normal semen proﬁles. Perhaps the successful sperm is not typical
of the cohorts analysed. If it is, the wisdom of using sperm with
damaged DNA is questionable even if it does result in pregnancies,
given the many animal studies showing adverse effects of DNA
damage on long-term health of offspring (reviewed by Aitken et al.,
2008; Fernadez-Gonzalez et al., 2008). In conclusion, this study adds
to the amassing wealth of literature by showing the usefulness of
sperm DNA testing in diagnosis of male infertility and that DF (or
potential DF) can predict ART outcome.
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